IGF1 and neoplasm: Taken together, the current study provided novel evidence that miR-26a is significantly downregulated in osteosarcoma clinical specimens and appears to function as a tumor suppressor in osteosarcoma through the regulation of IGF-1 expression and cell proliferation.